Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
May-2022 Volume 23 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2022 Volume 23 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Salvianolic acid B improves the survival rate, acute kidney dysfunction, inflammation and NETosis‑mediated antibacterial action in a crush syndrome rat model

  • Authors:
    • Isamu Murata
    • Tsugumi Sugai
    • Yumiko Murakawa
    • Yoshiaki Miyamoto
    • Jun Kobayashi
    • Yutaka Inoue
    • Ikuo Kanamoto
  • View Affiliations / Copyright

    Affiliations: Laboratory of Drug Safety Management, Faculty of Pharmacy and Pharmaceutical Science, Josai University, Sakado, Saitama 350‑0295, Japan, Laboratory of Pharmacotherapeutics and Neuropsychopharmacology, Faculty of Pharmacy and Pharmaceutical Science, Josai University, Sakado, Saitama 350‑0295, Japan, Laboratory of Pathophysiology, Faculty of Pharmacy and Pharmaceutical Science, Josai University, Sakado, Saitama 350‑0295, Japan
  • Article Number: 320
    |
    Published online on: March 10, 2022
       https://doi.org/10.3892/etm.2022.11249
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Crush syndrome (CS) is a potentially lethal condition characterized by muscle cell damage resulting from decompression following compression. Patients with CS can develop cardiac failure, kidney dysfunction, shock, systemic inflammation and sepsis. Salvianolic acid B (SalB) has cardiac and kidney protective effects and anti‑oxidative, anti‑inflammatory, anti‑apoptotic and anti‑bacterial properties. The present study aimed to demonstrate the survival benefit of SalB in the CS rat model, which comprised anesthetized rats with bilateral hindlimb compression by a rubber tourniquet for 5 h. The rats examined were randomly divided into four groups: i) Sham; ii) sham treated with SalB; iii) CS rat model without treatment; and iv) CS rat model treated with SalB. Under continuous monitoring and recording of arterial blood pressures, blood and tissue samples were collected for biochemical analyses at designated timepoints before and after reperfusion. SalB administration improved the survival rate, kidney function (by treating shock and metabolic acidosis) and inflammation (by reducing mitochondrial dysfunction and endothelial damage). Reduced incidence of cardiac failure due to hyperkalemia was associated with reduced muscle injury via the prevention of mitochondrial dysfunction. Additionally, indirect antibacterial action by the neutrophil extracellular trap system (NETs) was observed. SalB administration to the CS rat model led to a substantial improvement in survival following CS by decreasing kidney and cardiac dysfunctions, inflammation, and endothelial dysfunction by improving the mitochondrial function and through antibacterial effects via NETs.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Smith J and Greaves I: Crush injury and crush syndrome: A review. J Trauma. 54 (Suppl 5):S226–S230. 2003.PubMed/NCBI View Article : Google Scholar

2 

Bosch X, Poch E and Grau JM: Rhabdomyolysis and acute kidney injury. N Engl J Med. 361:62–72. 2009.PubMed/NCBI View Article : Google Scholar

3 

Sever MS and Vanholder R: RDRTF of ISN Work Group on Recommendations for the Management of Crush Victims in Mass Disasters. Recommendation for the management of crush victims in mass disasters. Nephrol Dial Transplant. 27 (Suppl 1):i1–i67. 2012.PubMed/NCBI View Article : Google Scholar

4 

Obialo CI, Okonofua EC, Nzerue MC, Tayade AS and Riley LJ: Role of hypoalbuminemia and hypocholesterolemia as copredictors of mortality in acute renal failure. Kidney Int. 56:1058–1063. 1999.PubMed/NCBI View Article : Google Scholar

5 

Bullock ML, Umen AJ, Finkelstein M and Keane WF: The assessment of risk factors in 462 patients with acute renal failure. Am J Kidney Dis. 5:97–103. 1985.PubMed/NCBI View Article : Google Scholar

6 

Sever MS, Erek E, Vanholder R, Koc M, Yavuz M, Aysuna N, Ergin H, Ataman R, Yenicesu M, Canbakan B, et al: Lessons learned from the catastrophic Marmara earthquake: Factors influencing the final outcome of renal victims. Clin Nephrol. 61:413–421. 2004.PubMed/NCBI View Article : Google Scholar

7 

Chertow GM, Christiansen CL, Cleary PD, Munro C and Lazarus JM: Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med. 155:1505–1511. 1995.PubMed/NCBI

8 

Gonzalez D: Crush syndrome. Crit Care Med. 33 (Suppl 1):S34–S41. 2005.PubMed/NCBI View Article : Google Scholar

9 

Tanaka H, Oda J, Iwai A, Kuwagata Y, Matsuoka T, Takaoka M, Kishi M, Morimoto F, Ishikawa K, Mizushima Y, et al: Morbidity and mortality of hospitalized patients after the 1995 Hanshin-Awaji earthquake. Am J Emerg Med. 17:186–191. 1999.PubMed/NCBI View Article : Google Scholar

10 

Vanholder R, Sever MS, Smet M, Erek E and Lameire N: Intervention of the renal disaster relief task force in the 1999 Marmara, Turkey earthquake. Kidney Int. 59:783–791. 2001.PubMed/NCBI View Article : Google Scholar

11 

Zhang L, Fu P, Wang L, Cai G, Zhang L, Chen D, Guo D, Sun X, Chen F, Bi W, et al: The clinical features and outcome of crush patients with acute kidney injury after the Wenchuan earthquake: Differences between elderly and younger adults. Injury. 43:1470–1475. 2012.PubMed/NCBI View Article : Google Scholar

12 

Ashkenazi I, Isakovich B, Kluger Y, Alfici R, Kessel B and Better OS: Prehospital management of earthquake casualties buried under rubble. Prehosp Disaster Med. 20:122–133. 2005.PubMed/NCBI View Article : Google Scholar

13 

Erek E, Sever MS, Serdengeçti K, Vanholder R, Akoğlu E, Yavuz M, Ergin H, Tekçe M, Duman N and Lameire N: Turkish Study Group of Disaster. An overview of morbidity and mortality in patients with acute renal failure due to crush syndrome: The Marmara earthquake experience. Nephrol Dial Transplant. 17:33–40. 2002.PubMed/NCBI View Article : Google Scholar

14 

Xue L, Wu Z, Ji XP, Gao XQ and Guo YH: Effect and mechanism of salvianolic acid B on the myocardial ischemia-reperfusion injury in rats. Asian Pac J Trop Med. 7:280–284. 2014.PubMed/NCBI View Article : Google Scholar

15 

Kong R, Gao Y, Sun B, Chen H, Wang G, Wang X, Zhu H, Pan S, Xue D and Jiang H: The strategy of combined ischemia preconditioning and salvianolic acid-B pretreatment to prevent hepatic ischemia-reperfusion injury in rats. Dig Dis Sci. 54:2568–2576. 2009.PubMed/NCBI View Article : Google Scholar

16 

Tang M, Feng W, Zhang Y, Zhong J and Zhang J: Salvianolic acid B improves motor function after cerebral ischemia in rats. Behav Pharmacol. 17:493–498. 2006.PubMed/NCBI View Article : Google Scholar

17 

Pan RH, Xie FY, Chen HM, Xu LZ, Wu XC, Xu LL and Yao G: Salvianolic acid B reverses the epithelial-to-mesenchymal transition of HK-2 cells that is induced by transforming growth factor-β. Arch Pharma Res. 34:477–483. 2011.PubMed/NCBI View Article : Google Scholar

18 

Han JY, Fan JY, Horie Y, Miura S, Cui DH, Ishii H, Hibi T, Tsuneki H and Kimura I: Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol Ther. 117:280–295. 2008.PubMed/NCBI View Article : Google Scholar

19 

Watzke A, O'Malley SJ, Bergman RG and Ellman JA: Reassignment of the configuration of salvianolic acid B and establishment of its identity with lithospermic acid B. J Nat Prod. 69:1231–1233. 2006.PubMed/NCBI View Article : Google Scholar

20 

Liu Q, Shi X, Tang L, Xu W, Jiang S, Ding W, Feng Q, Chu H, Ma Y, Li Y, et al: Salvianolic acid B attenuates experimental pulmonary inflammation by protecting endothelial cells against oxidative stress injury. Eur J Pharmacol. 840:9–19. 2018.PubMed/NCBI View Article : Google Scholar

21 

Katary MA, Abdelsayed R, Alhashim A, Abdelhasib M and Elmarakby AA: Salvianolic acid B slows the progression of breast cancer cell growth via enhancement of apoptosis and reduction of oxidative stress, inflammation, and angiogenesis. Int J Mol Sci. 20(5653)2019.PubMed/NCBI View Article : Google Scholar

22 

Huttunen S, Toivanen M, Liu C and Tikkanen-Kaukanen C: . Novel anti-infective potential of salvianolic acid B against human serious pathogen Neisseria meningitidis. BMC Res Notes. 9(25)2016.PubMed/NCBI View Article : Google Scholar

23 

Xinyue W, Wang L, Tang L, Wang L, Cao S, Wu Q, Zhang Z and Li L: Salvianolic acid B alters the gut microbiota and mitigates colitis severity and associated inflammation. J Funct Foods. 46:312–319. 2018.

24 

Murata I, Ooi K, Sasaki H, Kimura S, Ohtake K, Ueda H, Uchida H, Yasui N, Tsutsui Y, Yoshizawa N, et al: Characterization of systemic and histologic injury after crush syndrome and intervals of reperfusion in a small animal model. J Trauma. 70:1453–1463. 2011.PubMed/NCBI View Article : Google Scholar

25 

Murata I, Ooi K, Shoji S, Motohashi Y, Kan M, Ohtake K, Kimura S, Ueda H, Nakano N, Sonoda K, et al: Acute lethal crush-injured rats can be successfully rescued by a single injection of high-dose dexamethasone through a pathway involving PI3K-Akt-eNOS signaling. J Trauma Acute Care Surg. 75:241–249. 2013.PubMed/NCBI View Article : Google Scholar

26 

Murata I, Miyake Y, Takahashi N, Suzuki R, Fujiwara T, Sato Y, Inoue Y, Kobayashi J and Kanamoto I: Low-dose sodium nitrite fluid resuscitation prevents lethality from crush syndrome by improving nitric oxide consumption and preventing myoglobin cytotoxicity in kidney in a rat model. Shock. 48:112–118. 2017.PubMed/NCBI View Article : Google Scholar

27 

Murata I, Abe Y, Yaginuma Y, Yodo K, Kamakari Y, Miyazaki Y, Baba D, Shinoda Y, Iwasaki T, Takahashi K, et al: Astragaloside-IV prevents acute kidney injury and inflammation by normalizing muscular mitochondrial function associated with a nitric oxide protective mechanism in crush syndrome rats. Ann Intensive Care. 7(90)2017.PubMed/NCBI View Article : Google Scholar

28 

Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y and Zychlinsky A: Neutrophil extracellular traps kill bacteria. Science. 303:1532–1535. 2004.PubMed/NCBI View Article : Google Scholar

29 

Fuchs TA, Bhandari AA and Wagner DD: Histones induce rapid and profound thrombocytopenia in mice. Blood. 118:3708–3714. 2011.PubMed/NCBI View Article : Google Scholar

30 

Lin C, Liu Z, Lu Y, Yao Y, Zhang Y, Ma Z, Kuai M, Sun X, Sun S, Jing Y, et al: Cardioprotective effect of Salvianolic acid B on acute myocardial infarction by promoting autophagy and neovascularization and inhibiting apoptosis. J Pharm Pharmacol. 68:941–952. 2016.PubMed/NCBI View Article : Google Scholar

31 

Chang PN, Mao JC, Huang SH, Ning L, Wang ZJ, On T, Duan W and Zhu YZ: Analysis of cardioprotective effects using purified Salvia miltiorrhiza extract on isolated rat hearts. J Pharmacol Sci. 101:245–249. 2006.PubMed/NCBI View Article : Google Scholar

32 

Li Y, Zhang X, Cui L, Chen R, Zhang Y, Zhang C, Zhu X, He T, Shen Z, Dong L, et al: Salvianolic acids enhance cerebral angiogenesis and neurological recovery by activating JAK2/STAT3 signaling pathway after ischemic stroke in mice. J Neurochem. 143:87–99. 2017.PubMed/NCBI View Article : Google Scholar

33 

Paller MS, Hoidal JR and Ferris TF: Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest. 74:1156–1164. 1984.PubMed/NCBI View Article : Google Scholar

34 

Sharma OP and Bhat TK: DPPH antioxidant assay revisited. Food Chem. 113:1202–1205. 2009.

35 

Cockerill FR, Hindler JA, Wikler MA, Patel JB, Alder J, Powell M, Dudley MN, Swenson JM, Eliopoulos GM, Thomson RB, et al: Methods For Dilution Antimicrobial Susceptibility Tests For Bacteria That Grow Aerobically; Approved Standard. CLSI M7-A9. Vol 32. 9th edition. Clinical Laboratory Standards Institute, Wayne, PA, 2012.

36 

Scaffidi P, Misteli T and Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 418:191–195. 2002.PubMed/NCBI View Article : Google Scholar

37 

Lotze MT and Tracey KJ: High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol. 5:331–342. 2005.PubMed/NCBI View Article : Google Scholar

38 

Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:248–251. 1999.PubMed/NCBI View Article : Google Scholar

39 

Murata I, Imanari M, Komiya M, Kobayashi J, Inoue Y and Knamoto I: Icing treatment in rats with crush syndrome can improve survival through reduction of potassium concentration and mitochondrial function disorder effect. Exp Ther Med. 19:777–785. 2020.PubMed/NCBI View Article : Google Scholar

40 

Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH and Suffredini AF: Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 101:2652–2660. 2003.PubMed/NCBI View Article : Google Scholar

41 

Yang Q, Wang S, Xie Y, Wang J, Li H, Zhou X and Liu W: Effect of salvianolic acid B and paeonol on blood lipid metabolism and hemorrheology in myocardial ischemia rabbits induced by pituitruin. Int J Mol Sci. 11:3696–3704. 2010.PubMed/NCBI View Article : Google Scholar

42 

Ren M, Wang YM, Zhao J, Zhao J, Zhao ZM, Zhang TF, He J, Ren SP and Peng SQ: Metallothioneins attenuate paraquat-induced acute lung injury in mice through the mechanisms of anti-oxidation and anti-apoptosis. Food Chem Toxicol. 73:140–147. 2014.PubMed/NCBI View Article : Google Scholar

43 

Liu Y, Hu Y, E Q, Zuo J, Yang L and Liu W: Salvianolic acid B inhibits mitochondrial dysfunction by up-regulating mortalin. Sci Rep. 7(43097)2017.PubMed/NCBI View Article : Google Scholar

44 

Huang M, Wang P, Xu S, Xu W, Xu W, Chu K and Lu J: Biological activities of salvianolic acid B from Salvia miltiorrhiza on type 2 diabetes induced by high-fat diet and streptozotocin. Pharm Biol. 53:1058–1065. 2015.PubMed/NCBI View Article : Google Scholar

45 

Zhao DH, Wu YJ, Liu ST and Liu RY: Salvianolic acid B attenuates lipopolysaccharide-induced acute lung injury in rats through inhibition of apoptosis, oxidative stress and inflammation. Exp Ther Med. 14:759–764. 2017.PubMed/NCBI View Article : Google Scholar

46 

Li W, Qian J, Liu X, Zhang Q, Wang L, Chen D and Lin Z: Management of severe crush injury in a front-line tent ICU after 2008 Wenchuan earthquake in China: An experience with 32 cases. Crit Care. 13(R178)2009.PubMed/NCBI View Article : Google Scholar

47 

Hong CH: Current understanding in neutrophil differentiation and heterogeneity. Immune Netw. 17:298–306. 2017.PubMed/NCBI View Article : Google Scholar

48 

Zarbock A, Ley K, McEver RP and Hidalgo A: Leukocyte ligands for endothelial selectins: Specialized glycoconjugates that mediate rolling and signaling under flow. Blood. 118:6743–6751. 2011.PubMed/NCBI View Article : Google Scholar

49 

Lee YW, Kim DH, Jeon SJ, Park SJ, Kim JM, Jung JM, Lee HE, Bae SG, Oh HK, Son KH and Ryu JH: Neuroprotective effects of salvianolic acid B on an Aβ25-35 peptide-induced mouse model of Alzheimer's disease. Eur J Pharmacol. 704:70–77. 2013.PubMed/NCBI View Article : Google Scholar

50 

Baggiolini M, Dewald B and Moser B: Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol. 55:97–197. 1994.PubMed/NCBI

51 

Mukaida N, Hishinuma A, Zachariae CO, Oppenheim JJ and Matsushima K: Regulation of human interleukin 8 gene expression and binding of several other members of the intercrine family to receptors for interleukin-8. Adv Exp Med Biol. 305:31–38. 1991.PubMed/NCBI View Article : Google Scholar

52 

Gonzalez-Aparicio M and Alfaro C: Influence of interleukin-8 and neutrophil extracellular trap (NET) formation in the tumor microenvironment: Is there a pathogenic role? J Immunol Res. 2019(6252138)2019.PubMed/NCBI View Article : Google Scholar

53 

Parker H, Albrett AM, Kettle AJ and Winterbourn CC: Myeloperoxidase associated with neutrophil extracellular traps is active and mediates bacterial killing in the presence of hydrogen peroxide. J Leukoc Biol. 91:369–376. 2012.PubMed/NCBI View Article : Google Scholar

54 

Papayannopoulos V and Zychlinsky A: NETs: A new strategy for using old weapons. Trends Immunol. 30:513–521. 2009.PubMed/NCBI View Article : Google Scholar

55 

Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, Weinrauch Y, Brinkmann V and Zychlinsky A: Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 176:231–241. 2007.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Murata I, Sugai T, Murakawa Y, Miyamoto Y, Kobayashi J, Inoue Y and Kanamoto I: Salvianolic acid B improves the survival rate, acute kidney dysfunction, inflammation and NETosis‑mediated antibacterial action in a crush syndrome rat model. Exp Ther Med 23: 320, 2022.
APA
Murata, I., Sugai, T., Murakawa, Y., Miyamoto, Y., Kobayashi, J., Inoue, Y., & Kanamoto, I. (2022). Salvianolic acid B improves the survival rate, acute kidney dysfunction, inflammation and NETosis‑mediated antibacterial action in a crush syndrome rat model. Experimental and Therapeutic Medicine, 23, 320. https://doi.org/10.3892/etm.2022.11249
MLA
Murata, I., Sugai, T., Murakawa, Y., Miyamoto, Y., Kobayashi, J., Inoue, Y., Kanamoto, I."Salvianolic acid B improves the survival rate, acute kidney dysfunction, inflammation and NETosis‑mediated antibacterial action in a crush syndrome rat model". Experimental and Therapeutic Medicine 23.5 (2022): 320.
Chicago
Murata, I., Sugai, T., Murakawa, Y., Miyamoto, Y., Kobayashi, J., Inoue, Y., Kanamoto, I."Salvianolic acid B improves the survival rate, acute kidney dysfunction, inflammation and NETosis‑mediated antibacterial action in a crush syndrome rat model". Experimental and Therapeutic Medicine 23, no. 5 (2022): 320. https://doi.org/10.3892/etm.2022.11249
Copy and paste a formatted citation
x
Spandidos Publications style
Murata I, Sugai T, Murakawa Y, Miyamoto Y, Kobayashi J, Inoue Y and Kanamoto I: Salvianolic acid B improves the survival rate, acute kidney dysfunction, inflammation and NETosis‑mediated antibacterial action in a crush syndrome rat model. Exp Ther Med 23: 320, 2022.
APA
Murata, I., Sugai, T., Murakawa, Y., Miyamoto, Y., Kobayashi, J., Inoue, Y., & Kanamoto, I. (2022). Salvianolic acid B improves the survival rate, acute kidney dysfunction, inflammation and NETosis‑mediated antibacterial action in a crush syndrome rat model. Experimental and Therapeutic Medicine, 23, 320. https://doi.org/10.3892/etm.2022.11249
MLA
Murata, I., Sugai, T., Murakawa, Y., Miyamoto, Y., Kobayashi, J., Inoue, Y., Kanamoto, I."Salvianolic acid B improves the survival rate, acute kidney dysfunction, inflammation and NETosis‑mediated antibacterial action in a crush syndrome rat model". Experimental and Therapeutic Medicine 23.5 (2022): 320.
Chicago
Murata, I., Sugai, T., Murakawa, Y., Miyamoto, Y., Kobayashi, J., Inoue, Y., Kanamoto, I."Salvianolic acid B improves the survival rate, acute kidney dysfunction, inflammation and NETosis‑mediated antibacterial action in a crush syndrome rat model". Experimental and Therapeutic Medicine 23, no. 5 (2022): 320. https://doi.org/10.3892/etm.2022.11249
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team